US2020023063A1PendingUtilityA1
Compositions and methods useful for stabilizing protein-containing formulations
Est. expiryMar 22, 2030(~3.6 yrs left)· nominal 20-yr term from priority
C07K 16/42A61K 47/10C07K 16/244A61K 38/00A61K 9/2018A61K 39/395C07K 2317/94A61K 47/26A61K 47/12G01N 1/00A61K 39/39591C07K 16/4291A61K 39/00
60
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates to use of non-surfactant compounds including, for example, polyoxyethylene (POE) sorbitans and polyethylene glycols (PEGs), for stabilizing protein-containing formulations and for the prevention of aggregation of proteins in such formulations.
Claims
exact text as granted — not AI-modified1 - 24 . (canceled)
25 . A method of preparing a stabilized protein-containing formulation, said method comprising admixing a protein with a polyethylene glycol, wherein said polyethylene glycol is present at a concentration of 10,000 ppm or less, thereby providing said stabilized protein-containing formulation.
26 . The method of claim 25 , wherein said protein is an antibody.
27 . The method of claim 25 , wherein the polyethylene glycol is selected from the group consisting of PEG 1000 and PEG 6000.
28 . The method of claim 25 further comprising the step of lyophilizing said stabilized protein-containing formulation.
29 - 31 . (canceled)
32 . A method of increasing the stability of a protein in aqueous solution, said method comprising admixing said protein with a polyethylene glycol, wherein said polyethylene glycol is present at a concentration of 10,000 ppm or less and increases the stability of said protein in aqueous solution.
33 . The method of claim 32 , wherein said protein is an antibody.
34 . The method of claim 32 , wherein the polyethylene glycol is selected from the group consisting of PEG 1000 and PEG 6000.
35 - 37 . (canceled)
38 . A method of preventing or reducing the aggregation of a protein in aqueous solution, said method comprising admixing said protein with a polyethylene glycol, wherein said polyethylene glycol is present at a concentration of 10,000 ppm or less and prevents or reduces the aggregation of said protein in aqueous solution.
39 . The method of claim 38 , wherein said protein is an antibody.
40 . The method of claim 38 , wherein the polyethylene glycol is selected from the group consisting of PEG 1000 and PEG 6000.Join the waitlist — get patent alerts
Track US2020023063A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.